110 related articles for article (PubMed ID: 10530901)
21. Characterization of cementum derived growth factor as an insulin-like growth factor-I like molecule.
Ikezawa K; Hart CE; Williams DC; Narayanan AS
Connect Tissue Res; 1997; 36(4):309-19. PubMed ID: 9610889
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a heparin-binding growth factor from adenocarcinoma of the kidney.
Mydlo JH; Heston WD; Fair WR
J Urol; 1988 Dec; 140(6):1575-9. PubMed ID: 3193547
[TBL] [Abstract][Full Text] [Related]
23. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
Zhou FY; Kan M; Owens RT; McKeehan WL; Thompson JA; Linhardt RJ; Höök M
Eur J Cell Biol; 1997 May; 73(1):71-80. PubMed ID: 9174673
[TBL] [Abstract][Full Text] [Related]
24. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
Zarnegar R; Michalopoulos G
Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
[TBL] [Abstract][Full Text] [Related]
25. Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors.
Klagsbrun M; Shing Y
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):805-9. PubMed ID: 3856234
[TBL] [Abstract][Full Text] [Related]
26. Identification of the hepatocyte mitogen in bovine spleen as heparin-binding growth factors.
Suzuki M; Itoh T; Suzuki T; Koga N; Kato K; Saito T; Mitsui Y
Biochem Biophys Res Commun; 1992 Aug; 186(3):1192-200. PubMed ID: 1380796
[TBL] [Abstract][Full Text] [Related]
27. Effect of growth factors on matrix synthesis by ligament fibroblasts.
Marui T; Niyibizi C; Georgescu HI; Cao M; Kavalkovich KW; Levine RE; Woo SL
J Orthop Res; 1997 Jan; 15(1):18-23. PubMed ID: 9066522
[TBL] [Abstract][Full Text] [Related]
28. In-gel ligand blotting with 125I-heparin for detection of heparin-binding growth factors.
Murphy PR; Katsumata N; Sato Y; Too CK; Friesen HG
Anal Biochem; 1990 May; 187(1):197-201. PubMed ID: 2372116
[TBL] [Abstract][Full Text] [Related]
29. Growth factor from human milk: purification and characterization.
Kanda Y; Yamamoto N; Abe Y
Life Sci; 1994; 55(19):1509-20. PubMed ID: 7968218
[TBL] [Abstract][Full Text] [Related]
30. An androgen-dependent subclone derived from a mouse mammary tumor, Shionogi carcinoma 115, secretes a heparin-binding growth factor having an apparent molecular weight of 31,000 in response to androgen.
Kawamoto K; Yamaguchi T; Watanabe S; Uchida K
Biochim Biophys Acta; 1992 Apr; 1134(3):183-8. PubMed ID: 1558842
[TBL] [Abstract][Full Text] [Related]
31. Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation.
Marikovsky M; Vogt P; Eriksson E; Rubin JS; Taylor WG; Joachim S; Klagsbrun M
J Invest Dermatol; 1996 Apr; 106(4):616-21. PubMed ID: 8617994
[TBL] [Abstract][Full Text] [Related]
32. Identification of fibroblast growth factors in bovine cheese whey.
Rogers ML; Belford DA; Francis GL; Ballard FJ
J Dairy Res; 1995 Aug; 62(3):501-7. PubMed ID: 7593831
[TBL] [Abstract][Full Text] [Related]
33. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium.
Panos RJ; Rubin JS; Csaky KG; Aaronson SA; Mason RJ
J Clin Invest; 1993 Aug; 92(2):969-77. PubMed ID: 7688769
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor(TGF)-beta 1 induces leukemic cell-growth-promoting activity in fibroblast cells.
Komatsu K; Nakamura H; Akedo H
Cell Biol Int; 1993 Apr; 17(4):433-40. PubMed ID: 8318954
[TBL] [Abstract][Full Text] [Related]
35. Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression.
Blanquaert F; Barritault D; Caruelle JP
J Biomed Mater Res; 1999 Jan; 44(1):63-72. PubMed ID: 10397905
[TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of a growth factor from guinea pig harderian gland.
Yokoyama Y; Kano K; Kaji K; Seyama Y
J Biol Chem; 1989 Oct; 264(29):17058-63. PubMed ID: 2551893
[TBL] [Abstract][Full Text] [Related]
37. Prolactin regulation by heparin-binding growth factors expressed in mouse pituitary cell lines.
Hnasko R; Ben-Jonathan N
Endocrine; 2003; 20(1-2):35-44. PubMed ID: 12668866
[TBL] [Abstract][Full Text] [Related]
38. Mitogenic effects of transforming growth factor type e on epithelial and fibroblastic cells--comparison with other growth factors.
Brown CA; Halper J
Exp Cell Res; 1990 Oct; 190(2):233-42. PubMed ID: 2209726
[TBL] [Abstract][Full Text] [Related]
39. Partial purification and characterization of a growth factor from human hyperplastic prostatic tissues.
Dignass A; Holldorf AW
Urol Res; 1992; 20(2):133-8. PubMed ID: 1372771
[TBL] [Abstract][Full Text] [Related]
40. Modulation of growth of human carcinoma SW-13 cells by heparin and growth factors.
Halper J; Carter BJ
J Cell Physiol; 1989 Oct; 141(1):16-23. PubMed ID: 2777898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
